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http://www.biomedcentral.com/1746-6148/10/17RESEARCH ARTICLE Open AccessAntimicrobial resistance and characterisation of
staphylococci isolated from healthy Labrador
retrievers in the United Kingdom
Vanessa M Schmidt1,6*†, Nicola J Williams2†, Gina Pinchbeck2†, Caroline E Corless3†, Stephen Shaw4†,
Neil McEwan1,6†, Susan Dawson2† and Tim Nuttall5†Abstract
Background: Coagulase-positive (CoPS) and coagulase-negative (CoNS) staphylococci are normal commensals of
the skin and mucosa, but are also opportunist pathogens. Meticillin-resistant (MR) and multidrug-resistant (MDR)
isolates are increasing in human and veterinary healthcare. Healthy humans and other animals harbour a variety of
staphylococci, including MR-CoPS and MR-CoNS. The main aims of the study were to characterise the population
and antimicrobial resistance profiles of staphylococci from healthy non-vet visiting and non-antimicrobial treated
Labrador retrievers in the UK.
Results: Nasal and perineal samples were collected from 73 Labrador retrievers; staphylococci isolated and
identified using phenotypic and biochemical methods. They were also confirmed by matrix-assisted laser desorption
ionisation time-of-flight mass spectrometry (MALDI-TOF-MS), PCR of the nuc gene and PCR and sequencing of the
tuf gene. Disc diffusion and minimum inhibitory concentration (MIC) susceptibility tests were determined for a
range of antimicrobials. In total, 102 CoPS (S. pseudintermedius n = 91, S. aureus n = 11) and 334 CoNS isolates were
detected from 99% of dogs in this study. In 52% of dogs CoNS only were detected, with both CoNS and CoPS
detected in 43% dogs and CoPS only detected in 4% of dogs. Antimicrobial resistance was not common among
CoPS, but at least one MDR-CoNS isolate was detected in 34% of dogs. MR-CoNS were detected from 42% of dogs
but no MR-CoPS were isolated. S. epidermidis (52% of dogs) was the most common CoNS found followed by S.
warneri (30%) and S. equorum (27%), with another 15 CoNS species isolated from ≤ 15% of dogs. S. pseudintermedius
and S. aureus were detected in 44% and 8% of dogs respectively.
Conclusions: MR- and MDR-CoPS were rare. However a high prevalence of MR- and MDR-CoNS were found in
these dogs, even though they had no prior antimicrobial treatment or admission to veterinary premises. These
findings are of concern due to the potential for opportunistic infections, zoonotic transmission and transmission of
antimicrobial resistant determinants from these bacteria to coagulase positive staphylococci.
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Staphylococci are normal commensal bacteria of the skin
and mucous membranes of humans and other animals.
They can be differentiated by their ability to produce
coagulase, with coagulase positive (CoPS) staphylococci
regarded as more pathogenic than coagulase negative
(CoNS) species [1-5].
Healthy humans and other animals may harbour mul-
tiple species and strains of staphylococci. Staphylococcus
aureus is the main human commensal CoPS species and
is carried in the nasal cavity of approximately 30% of
healthy people [6]. S. epidermidis is the most common
CoNS isolated from the nares, perineum, inguinal skin,
axillae and interdigital skin in man [2,7]. The main com-
mensal CoPS of dogs, S. pseudintermedius [8], has been
isolated from 37% to 92% of healthy dogs [9-14], while
S. aureus is carried by 4.3% to 12% of healthy dogs
[10,12,15-20]. Other species isolated from the mucosa
and skin of healthy dogs include the CoPS S. schleiferi
subspecies coagulans [10,21] and numerous CoNS (S.
schleiferi subspecies schleiferi, S. epidermidis, S. haemolyti-
cus, S. saprophyticus, S. devriesei, S. warneri, S. simulans,
S. xylosus, S.capitus, S. caprae, and S. sciuri) [12,15,22-26].
The carriage rate of CoNS isolated from the nasal mu-
cosae of healthy dogs was reported to be 38% in one large
cross-sectional study [15].
Staphylococci are frequent opportunistic pathogens
and commensal isolates are the most common source of
infection in humans [3] and dogs [12,16,27]. Antimicro-
bial resistance can increase the morbidity, mortality and
treatment cost of staphylococcal infections. Meticillin (oxa-
cillin) resistance associated with carriage of the mecA gene
confers resistance to all β-lactam antimicrobials [28]. The
mecA gene is located on a large mobile genetic element,
the staphylococcal cassette chromosome mec (SCCmec),
enabling horizontal transmission between staphylococcal
isolates [29]. Meticillin resistant staphylococci (MRS) are
important pathogens in human and veterinary healthcare
and are often multi-drug resistant (MDR; resistant to three
or more classes of antimicrobial) [30-35], extremely limit-
ing therapeutic options. MRSP clones with a broader
resistance spectrum than MRSA or MR-CoNS are increas-
ingly reported in domestic animals throughout Europe,
USA and Canada [32,34]. MR-CoNS are associated with
infections in humans and animals [31,36-38]. In humans
the most prevalent species is MR S. epidermidis (MRSE),
which may be a reservoir of MR for S. aureus [39,40]. In
addition, the SCCmec cassette of the major European
MRSP clone (ST71-J-t02-II–III) [34] consists of a combin-
ation of SCCmec II from MRSE and SCCmec III from
MRSA [41].
The prevalence of MRSA and MRSP carriage in
healthy humans and dogs in the community is low
[11,18,36,42-47]. However, human community-basedsurveys report a wider range of carriage rates for MR-
CoNS (11–50%) [39,48,49]. MR-CoNS have also been
isolated from the carriage sites of 13% of healthy dogs
[23,50]. The reported prevalence of MRS is higher in
animals exposed to veterinary healthcare environments
and antimicrobial therapy [47,51-53] suggesting that
these are risk factors for colonisation.
Previous studies looking at the commensal staphylo-
cocci in dogs have concentrated on CoPS species, particu-
larly MR-CoPS species, the CoNS group or MR-CoNS
species [9-11,13,14,17,23,50], but no study has charac-
terised the complete canine commensal staphylococcal
population. Moreover, reporting of the antimicrobial treat-
ment history of dogs in these studies have been inconsist-
ent. The aim of this study was to characterise the mucosal
staphylococcal population structure and antimicrobial
resistance profiles in healthy Labrador retrievers in the
UK in the absence of antimicrobial pressure. This will be
important in understanding changes in staphylococcal
populations and their antimicrobial susceptibility patterns
in dogs exposed to antimicrobials and other risk factors.
Methods
Study population
Labrador retriever dogs were recruited for the study from
dog shows in the UK between November 2010 and June
2011. One healthy dog was enrolled from each household
if the dog had not received topical or systemic antimicro-
bial therapy, or had not been admitted to a veterinary
clinic within the last 12 months. All dog owners gave
written informed consent before enrolment in this study
and completed a questionnaire regarding potential risk
factors for the carriage of antimicrobial resistant bacteria.
The University of Liverpool School of Veterinary Science
ethics committee approved the study protocol.
Staphylococci
Specimen collection and bacterial isolation
One nasal swab and one perineal swab were collected
from each dog (Copan Eswab LQ Amies Minitip Nylon
Flocked Applicator, Appleton Woods, Birmingham, UK).
A sterile swab was either inserted 5 mm into one nostril
or rubbed on the skin of the perineum for 3–5 seconds
before being placed in Amies transport media, stored at
4°C and processed within 36 hours. Swabs were incu-
bated aerobically overnight at 37°C in nutrient broth
with 6.5% sodium chloride. The broth was streaked onto
mannitol salt agar (MSA), oxacillin resistance screening
agar (ORSA) supplemented with 2 μg/ml of oxacillin and
Columbia 5% horse blood agar (CAB), and incubated
aerobically overnight at 37°C. Where present, isolates typ-
ical of staphylococci were selected from all plates, sub-
cultured onto CAB and incubated aerobically overnight at
37°C. Fresh staphylococcal cultures on CAB were subject
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UK), tested for catalase (Sigma-Aldrich Company Ltd.,
Gillingham, UK) and free coagulase production (Rabbit
plasma, Pro-Lab, Bromborough, UK) according the manu-
facturer’s instructions and stored at − 80°C in Microbank
vials (Pro-Lab, Bromborough, UK). All media were obtained
from LabM Ltd, Bury, UK.
Antimicrobial susceptibility testing
Disc diffusion testing was performed on all staphylococ-
cal isolates in accordance with the Clinical and Labora-
tory Standards Institute (CLSI) and the following panel
of ten antimicrobial discs were applied: 1 μg oxacillin
(OX), 1 μg ciprofloxacin (CIP), 10 μg gentamicin (GM),
10 μg fusidic acid (FA), 30 μg cefalexin (CFX), 30 μg
cefovecin (CVN), 25 μg trimethoprim-sulfamethoxazole
(TS), 10 μg tetracycline (Tet), 2 μg clindamycin (CD)
and 5 μg vancomycin (Va) [54]. All the discs were pur-
chased from MAST Group Ltd., Liverpool, UK, except
for CVN, which were obtained from Oxoid, Basingstoke,
UK. Micro-dilution susceptibility testing (Trek Diagnos-
tic Systems, Cleveland, Ohio, USA) was performed on a
subset of the CoNS isolates using the same antimicrobial
panel, except vancomycin [54]. Interpretation was based
on the CLSI guidelines for animal species-specific zone
diameter (mm) interpretive standards and minimal inhibi-
tory concentration (MIC; mg/l) breakpoints for veterinary
pathogens or human-derived interpretive standards when
available. The European Committee on Antimicrobial
Susceptibility Testing (EUCAST) zone diameter interpret-
ive standards and MIC breakpoints were used for CIP and
FA [55]. The breakpoints used for interpretation of OX re-
sistance were a zone of inhibition of ≤ 17 mm and MIC ≥
0.5 mg/l for S. pseudintermedius and CoNS, and ≤ 10 mm
and MIC ≥ 4 mg/l for S. aureus [56,57]. The breakpoints
used for interpretation of resistance to CVN as a zone of
inhibition of ≤ 19 mm and MIC ≥ 8 mg/l in accordance
with the manufacturer’s recommendations. The reference
strain S. aureus ATCC®25923 (LGC Standards, Teddington,
UK) was used for quality control for MIC and zone
diameter determinations.
DNA extraction
Three colonies of each staphylococcal isolate were
homogenised in 90 μl of sterile distilled water (SDW)
and 10 μl of lysostaphin (1 mg/ml; Sigma-Aldrich Com-
pany Ltd., Gillingham, UK) and vortexed for 5 seconds.
The suspensions were then incubated at 37°C for 10 mi-
nutes and heated at 100°C for 10 minutes before adding
400 μl of SDW. Samples were stored at 4°C.
Characterisation of antimicrobial resistance genes
PCR assays were performed to detect the presence of
mecA gene (Table 1) in staphylococcal isolates that werephenotypically resistant to oxacillin. All the PCR assays
were performed with 0.5 μl of each primer (10 pmol/μl),
1 μl of DNA and 1.1x PCR master mix (ReddyMix™,
Thermo Fisher Scientific Inc., Surrey, UK) made up to a
total reaction volume of 25 μl. Molecular grade water
(Sigma-Aldrich Company Ltd., Gillingham, UK) was
used as the negative control in all PCR assays. PCR
products were analysed by agarose gel (1.5%) electro-
phoresis and the DNA fragments were visualised under
UV light after ethidium bromide staining.
Species identification
Genotypic species identification
PCR assays to detect the presence of the nuc genes of S.
pseudintermedius, S. aureus and S. schleiferi were per-
formed on all CoPS isolates using Qiagen® Multiplex
PCR Mix (Qiagen, Crawley, UK), according to the man-
ufacturer’s instructions with minor modifications. In
short, the PCR assays were performed in a reaction vol-
ume of 25 μl, consisting of 5 μl of bacterial DNA extract,
12.5 μl of master mix, 2.5 μl of 10x primer mix (2 μM of
each primer) and 5 μl of RNase-free water. The cycling
conditions consisted of an initial activation step at 95°C
for 15 minutes, followed by 30 cycles of 95°C for 30
seconds, 57°C for 90 seconds and 72°C for 60 seconds, and
a final extension step at 72°C for 10 minutes (Table 1).
MALDI-TOF-MS
All isolates were subjected to matrix-assisted laser desorp-
tion ionisation time-of-flight mass spectrometry (MALDI-
TOF-MS) according to the manufacturer’s protocol. Raw
spectra were analysed by the MALDI Biotyper 2.0 soft-
ware programme with default settings (Bruker Daltonics,
Bremen, Germany). The extraction method was per-
formed as previously described [58] on overnight col-
onies grown on CAB at 37°C and all isolates were tested
in duplicate. The bacterial test standard (E. coli DH5
alpha, Bruker, Bremen, Germany) was used for calibra-
tion before each experiment and included in duplicate
on each target plate. The mass peak profiles were matched
to the reference database and a score generated based on
similarity [59].
Sequencing
Two subsets of isolates detected from our group of dogs
underwent sequencing following PCR amplification of the
tuf gene [59,60]; a control group of CoNS isolates (n = 27)
identified by MALDI-TOF-MS and a test group of isolates
(n = 52) that had not been identified by MALDI-TOF-MS.
Initial PCR assays were performed using HotStarTaq®
Master Mix Kit (Qiagen, Crawley, UK) in a 25 μl reaction
volume with an initial activation step at 95°C for 15 mi-
nutes followed by 35 cycles of 95°C for 30 seconds, 55°C
for 30 seconds and 72°C for 30 seconds, with a final
Table 1 Details of PCR assays used in this study for nuc, tuf and mecA gene identification
Primer Sequence (5′-3′) Amplicon
size (bp)
Annealing
Temperature (°C)
Control strain Reference
au-F3 TCGCTTGCTATGATTGTGG 359 57 S. aureus ATCC®25923 (LGC Standards,
Teddington, UK)
[77]
au-nucR* GCCAATGTTCTACCATAGC
pse-F2 TRGGCAGTAGGATTCGTTAA 926 57 S. pseudintermedius (clinical isolate)
pse-R5* CTTTTGTGCTYCMTTTTGG
SSnucF AATGGCTACAATGATAATCACTAA 526 57 S. schleiferi subspecies coagulans
ATCC®49545
SSnucR* CATATCTGTCTTTCGGCGCG
tuf-F GCCAGTTGAGGACGTATTCT 412 55 S. epidermidis ATCC®12228 [105]
tuf-R CCATTTCAGTACCTTCTGGTAA
mecAF TGGCTATCGTGTCACAATCG 310 55 MRSA (clinical isolate) [103,104]
mecAR CTGGAACTTGTTGAGCAGAG
mA1 TGCTATCCACCCTCAAACAGG 286 57
mA2 AACGTTGTAACCACCCCAAGA
(*multiplex assay).
Schmidt et al. BMC Veterinary Research 2014, 10:17 Page 4 of 14
http://www.biomedcentral.com/1746-6148/10/17extension step of 72°C for 5 minutes according to the
manufacturer’s protocol. The resulting amplicons were
sequenced using BigDye Terminator version 1.1 cycle
sequencing (Applied Biosystems, Foster City, CA, USA)
according to the manufacturer’s protocol on the ABI3131
genetic analyser at the Department of Microbiology, Royal
Liverpool University Hospital. The sequences were aligned
using the ABI Sequencing analysis software, with contigu-
ous sequences matched to the GenBank database using
the Basic Local Alignment Search Tool (BLAST) [61] and
positively identified if there was ≥ 98% sequence similarity
with a reference sequence. S. epidermidis ATCC®12228
was used as the control strain.Statistical analysis
Data were analysed using SPSS software package (SPSS
20.0 for Mac, SPSS Inc, Chicago, Illinois).
To examine the association between isolation of S.
pseudintermedius with each of the 16 different CoNS
species Pearson’s chi-square was calculated (P < 0.003;
Bonferroni correction). To examine the association be-
tween MR and MDR with potential risk factors (previous
antimicrobial therapy or hospitalisation within 12 months
of enrolment, health-care or large animal-association by
in-contact people or pets) identified from the question-
naires Pearson’s chi-square was calculated (P < 0.0125;
Bonferroni correction). To examine the agreement be-
tween antimicrobial susceptibility tests by disc diffusion
and MIC a kappa statistic was calculated [62] and an
independent t-test was conducted to compare the MIC of
oxacillin resistant CoNS isolates that were either positive
or negative for the mecA gene.Results
Staphylococci
Specimen collection
Seventy-three Labrador retriever dogs were recruited.
Twenty-one dogs were aged between 3 to 12 months, 25
dogs were aged between 12 months to 2 years, and 27
dogs were > 2 years old, with 35 female dogs and 38
male dogs in total.
Bacterial isolation
Staphylococci were isolated from in 72 out of 73 dogs
(99%; 95% confidence interval (CI): 99.6-95.8) and from
both sample sites in the majority of dogs (78%; 95% CI:
67.3, 86.0). Isolation of staphylococci from the nasal mu-
cosae (16%, 95% CI 9.7, 26.6) or perineum (4%, 95% CI
1.4, 11.4) only occurred in a small number of dogs. If
only the nasal mucosae had been sampled, CoPS (all S.
pseudintermedius) would not have been detected in
seven dogs (10%, 95% CI 4.7, 18.5) and CoNS in six dogs
(8%, 95% CI 3.8, 16.8). CoNS were detected in the ma-
jority of dogs (95%, 95% CI 86.7, 97.8) either alone (52%,
95% CI 40.8, 63.1) or with CoPS (43%, 95% CI 31.8, 53.9).
Detection of CoPS alone was significantly less common
(4%, 95% CI 1.4, 11.4). In total, there were 436 staphylo-
coccal isolates; 102 of which were CoPS and 334 were
CoNS isolates.
Antimicrobial susceptibility testing by disc diffusion
The overall prevalence of antimicrobial resistance among
the isolates detected in this study appeared high, with at
least one MDR isolate detected in 34% of dogs. Anti-
microbial resistant CoNS isolates were detected in more
dogs than antimicrobial resistant CoPS isolates for OX,
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least one OX resistant isolate was detected in 58% dogs
(n = 126 oxacillin resistant isolates), but resistance to the
other tested β-lactam antimicrobials, CVN (25%) and
CFX (29%), was less common. Few CoPS demonstrated
antimicrobial resistance; isolates from twelve dogs had
Tet resistance (all S. pseudintermedius), seven with FA
resistance (S. pseudintermedius = 5, S. aureus = 3); two
with TS resistance (both S. pseudintermedius); two with
CD resistance (S. pseudintermedius = 1, S. aureus = 1)
and two with CIP resistance (both S. pseudintermedius).
MDR CoPS was detected from only one dog (S. pseudin-
termedius with FA, Tet and CD resistance) (Figure 1).
MIC compared to disc diffusion testing for
antimicrobial resistance
Micro-dilution susceptibility testing (Trek Diagnostic
Systems, Cleveland, Ohio, USA) was performed on 172
CoNS isolates, of which 52 were OX susceptible and 120
were OX resistant by disc diffusion. The OX resistant
isolates were further divided into those found to be posi-
tive (n = 74) or negative (n = 46) for carriage of the mecA
gene by PCR. The strength of agreement between anti-
microbial resistance detected by MIC and disc diffusion0
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Figure 1 The proportion of dogs (n = 73) carrying at least one staphy
mecA gene positive oxacillin resistance by the disc diffusion method.was very good for OX, GM, CVN, Tet and CD resist-
ance, good for CFX and TS resistance and moderate for
CIP (Kappa = 0.593) and FC resistance (Kappa = 0.589).
MIC testing identified more isolates as resistant to OX,
GM, CFX, CVN and Tet compared to disc diffusion, and
disc diffusion identified more isolates as resistant to CIP,
FA, TS and CD compared to MIC testing (Table 2).
Characterisation of antimicrobial resistance genes
Of the 126 OX resistant CoNS isolates detected by disc
diffusion, 75 isolates (60%, 95% CI 51, 68) from 31 dogs
(42%, 95% CI 32, 54) were positive for the mecA gene
(Figure 1). Nine additional oxacillin resistant isolates
were detected by MIC and two of these were positive for
the mecA gene, resulting in two additional dogs with
MR-CoNS and one additional dog with phenotypic oxa-
cillin resistant CoNS. There was a significant difference
between the MIC of mecA positive (M= 3.84, SD = 0.18)
and mecA negative isolates (M= 0.97, SD = 0.12, P < 0.001).
In addition the epidemiological breakpoint for OX resistant
CoNS isolates with mecA gene carriage isolated in this
study was consistent with the clinical CLSI breakpoint
(≥ 0.5 mg/l) (Figure 2). Eleven different CoNS species
(S. epidermidis, S. warneri, S. sciuri, S. equorum, S. fleurettii,X CVN Tet TS CD MDR
timicrobial
Total
CoNS
CoPS
lococcal isolate with resistance to each antimicrobial, MDR and
Total = CoNS and CoPS.
Table 2 Cross tabulation of the results of 172
staphylococcal isolates classified as resistant or
susceptible to the antimicrobials tested in this study by
both MIC and disc diffusion testing
Antimicrobial
resistance
MIC
No Yes Total
Oxacillin (OX) Disc diffusion No 50 10 60
Yes 2 110 112
Total 52 120 172
Kappa = 0.842
No Yes Total
Oxacillin mecA
positive
No 115 0 115
Yes 1 56 57
Total 116 56 172
Kappa = 0.987
No Yes Total
Ciprofloxacin (CIP) No 146 0 157
Yes 14 12 15
Total 160 12 172
Kappa = 0.593
No Yes Total
Gentamicin (GM) No 156 1 157
Yes 0 15 15
Total 156 16 172
Kappa = 0.965
No Yes Total
Fusidic acid (FA) No 36 5 41
Yes 25 106 131
Total 61 111 172
Kappa = 0.589
No Yes Total
Cefalexin (CFX) No 117 15 132
Yes 0 40 40
Total 117 55 172
Kappa = 0.784
No Yes Total
Cefovecin (CVN) No 130 11 141
Yes 0 31 31
Total 130 42 172
Kappa = 0.810
No Yes Total
Tetracycline (T10) No 148 1 149
Yes 0 23 23
Total 148 24 172
Kappa = 0.975
Table 2 Cross tabulation of the results of 172
staphylococcal isolates classified as resistant or
susceptible to the antimicrobials tested in this study by
both MIC and disc diffusion testing (Continued)
Yes Total
Trimethoprim-
sulfamethoxazole (TS)
No 156 2 158
Yes 3 11 14
Total 159 13 172
Kappa = 0.799
No Yes Total
Clindamycin (CD) No 148 2 150
Yes 4 18 22
Total 152 20 172
Kappa = 0.837
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cinus and S. pettenkoferi) were found to carry the mecA
gene. Among oxacillin resistant CoNS species, S epidermi-
dis and S. sciuri were more likely to carry the mecA gene
than S. saprophyticus, S. equorum, S. vitulinus and S. succi-
nus (Figure 3). MRSE isolates were detected in 18 dogs
(25%, 95% CI 14.8, 34.5), meticillin-resistant S. warneri were
detected in 7 dogs (10%, 95% CI 2.8, 16.3) and meticillin-
resistant S. sciuri were detected in 5 dogs (7%, 95% CI 1.1,
12.6). The remaining species were only isolated from one
or two dogs. MDR mecA positive CoNS were detected in
19 dogs (26%, 95% CI 17.3, 37.1). There was no significant
association between detection of MR-CoNS or MDR
isolates and potential risk factors tested in this study
(Pearson’s chi-square; P < 0.0125).Species identification
Phenotypic and biochemical methods identified 436
isolates as Staphylococcus species. Using a combination of
nuc gene PCR, MALDI-TOF-MS and sequencing of the tuf
gene, 399 isolates (92%, 95% CI 88.5, 93.8) were identi-
fied to the species level. MALDI-TOF-MS identified
345 isolates to the species level including 264 of 334
CoNS isolates (79%, 95% CI 74.4, 83.1). Amplification
and sequencing of the tuf gene identified 33 out of 51
CoNS isolates (65%, 95% CI 51, 76.4) to the species level
(n = 11 species; ≥ 98% sequence similarity) and an add-
itional control group (n = 27) of CoNS isolates that had
also been identified by MALDI-TOF-MS. There was
100% agreement between the two methods for the iden-
tification of the control group. In particular, sequencing
of the tuf gene identified all of the S. fleurettii, S. arlettae
and S. pettenkoferi isolates, 12 isolates closely related to
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Figure 2 The MIC (μg/ml) data for staphylococcal isolates (n = 172). The isolates consisted of 52 oxacillin susceptible isolates, 46 oxacillin
resistant mecA negative isolates and 74 oxacillin resistant mecA positive isolates.
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isolates to the genus level (Staphylococcus spp. ≥ 98%
sequence similarity). PCR amplification of the nuc gene
detected all of the S. aureus n = 11 (100%, 95% CI 74.1,
100) and S. pseudintermedius isolates n = 91 (100%, 95%
CI 96.0, 100). There was 100% agreement of this assay
with MALDI-TOF-MS for the identification of S. aureus0
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Figure 3 The percentage of each oxacillin-resistant staphylococcal sp
or negative (mecA-) for the mecA gene.isolates, however MALDI-TOF-MS only identified 69
out of 91 S. pseudintermedius isolates.
Overall from the combined results using PCR amplifi-
cation of the nuc gene, MALDI-TOF-MS and sequen-
cing of the tuf gene we detected S. epidermidis in 52%
(95% CI 41, 63) and S. pseudintermedius in 44% (95% CI
33, 55) of the dogs. S. warneri and S. equorum were themecA+
mecA-
ecies by disc diffusion and MIC that was either positive (mecA+)
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of dogs respectively, and the remaining staphylococcal
species were carried by no more than 15% of the dogs.
S. aureus was detected in 6 of the dogs, exclusively from
the nasal mucosae, and usually with S. pseudintermedius
(88%, 95% CI 52.9, 97.8). S. pseudintermedius was concur-
rently isolated with 16 different CoNS species, although
there was no significant association between the presence
of S. pseudintermedius and any CoNS species (Pearson’s
chi-square; P < 0.003) (Figure 4 and Table 3).
Discussion
This is the first study incorporating MALDI-TOF-MS to
successfully characterise commensal staphylococcal pop-
ulations in a group of healthy dogs in the absence of0
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Figure 4 The percentage of dogs (n = 73) carrying each staphylococca
nuc gene and sequencing of the tuf gene (CoNS grey and CoPS blackantimicrobial pressure. We isolated staphylococci from
99% of our dogs, with 95% carrying CoNS and 47% car-
rying CoPS. The relative prevalence of the staphylococci
concurs with other published studies in humans [2,3],
horses [63-67] and dogs [15,17,68], although the overall
staphylococcal prevalence was double that reported for
healthy vet visiting dogs [15]. This could be related to
the study population and techniques, as we sampled
both the nose and the perineum to increase detection of
CoPS [12,13,68,69].
We were able to assign 92% of the staphylococcal
isolates to 20 different species, including 18 CoNS. This is
the first study to demonstrate such diversity in dogs, and
carriage of this number of different species has only been
previously reported for humans [2,10,12,15,21-26,70]. Thel species identified in this study by MALDI-TOF-MS, PCR of the
).
Table 3 The number of staphylococcal isolates identified to species level by MALDI-TOF-MS, nuc gene PCR (CoPS), and
tuf gene sequencing
Staphylococcal species Number of isolates Number (%) of
positive dogs
Number (%) identified by
MALDI-TOF-MS
Number (%) of CoPS
identified by nuc PCR
Number (%) identified
by tuf gene sequencing
S. pseudintermedius 91 32 (44) 70 (77) 91 (100) 0
S. aureus 11 6 (8) 11 (100) 11 (100) 0
S. epidermidis 67 38 (52) 64 (96) N/A 3 (4)
S. warneri 35 22 (30) 35 (100) N/A 0
S. equorum 39 20 (27) 36 (92) N/A 3 (8)
S. saprophyticus 19 11 (15) 15 (79) N/A 4 (21)
S. sciuri 27 11 (15) 21 (78) N/A 6 (22)
S. succinus 19 10 (14) 16 (84) N/A 3 (16)
S. simulans 15 9 (12) 15 (100) N/A 0
S. capitus 7 8 (11) 7 (100) N/A 0
S. pasteuri 8 6 (8) 8 (100) N/A 0
S. xylosus 17 6 (8) 17 (100) N/A 0
S. lentus 9 5 (7) 4 (44) N/A 5 (56)
S. hominis 6 4 (5) 6 (100) N/A 0
S. cohnii 5 3 (4) 3 (60) N/A 2 (40)
S. vitulinus 14 3 (4) 13 (93) N/A 1 (7)
S. haemolyticus 4 3 (4) 4 (100) N/A 0
S. fleurettii 4 2 (3) 0 N/A 4 (100)
S. arlettae 1 1 (1) 0 N/A 1 (100)
S. pettenkoferi 1 1 (1) 0 N/A 1 (100)
Total ID 399d 72e 345f 101f 33f
Staphylococcus spp. 3 N/A N/A N/A 3
Species related to S. felis 12 N/A N/A N/A 12
No ID 22 N/A N/A 2 3
Total 436a 73b 436c 102c 51c
Values in the table are expressed as total numbers and percentage in parenthesis where applicable. aTotal number of isolates in study, btotal number of dogs in
study, ctotal number of isolates tested by each method, dtotal number of isolates with positive identification (ID), enumber of dogs with staphylococcal detection,
fnumber of isolates with positive ID from each method.
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detected in 52% of the dogs, mainly from the nasal cavity.
This is similar to human reports [71], but apart from one
canine study [23], S. epidermidis has not been commonly
reported in different animal species [67,72,73]. S. pseudin-
termedius was the second most common species and the
most common CoPS detected, also in agreement with
previous reports [9-11,13]. Unlike S. epidermidis, S.
pseudintermedius was carried equally in the nose and
on the perineum, suggesting that this species may have
a wider range of mucosal niches. Very few dogs carried
S. aureus (8%), which is comparable to other studies
that reported carriage rates of approximately 7% from
healthy vet visiting dogs [12,15]. The majority of the CoNS
in our study were human-associated and included S. epi-
dermidis, S. hominis, S. haemolyticus, S. capitus, S. sapro-
phyticus, S. warneri, S. cohnii, S. simulans, S. pettenkoferi
and S. pasteuri. Human associated CoNS species havepreviously been isolated from dogs, horses, cows and pigs
[23,67,72,74-76]. The other CoNS species isolated from
our dogs are reported as indigenous to animals (S.
equorum, S. vitulinus, S. arlettae S. sciuri, S. lentus and
S. fleurettii) [2].
We used several methods to identify staphylococcal
isolates to species level. Multiplex PCR for the nuc gene
is an accurate, rapid and cost efficient method to speciate
CoPS [77], which identified 100% of our S. pseudinterme-
dius (n = 91) and 100% of our S. aureus isolates (n = 11).
Recently MALDI-TOF-MS has been reported as a rapid
and reliable method to characterise CoNS, S. aureus and
S. intermedius group (SIG) strains [59,72,78-80]. MALDI-
TOF-MS identified all of our S. aureus isolates, 77% of
our S. pseudintermedius isolates and 79% of our CoNS
isolates, identified by phenotypic and biochemical charac-
teristics, to the species level. Similar results for the identi-
fication of S. aureus, S. pseudintermedius and CoNS by
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have been reported [79-81]. The overall performance of
MALDI-TOF-MS to speciate the staphylococcal isolates
in this study, similar to other reports [80], is likely to be
directly related to the database, which at the time of ana-
lysis consisted mainly of common human-derived species
and only one S. pseudintermedius strain. However species
level identification will improve as more highly charac-
terised reference isolates are added to the database. Amp-
lification and sequencing of the tuf gene is regarded as the
gold standard to speciate CoNS isolates [59,60]. This
method identified 77% of the tested staphylococcal isolates
(n = 79) to the species level. The performance of this
method in our study may have been affected by the lack of
certain-animal derived isolates representing different spe-
cies in the database. Additionally, we may have improved
identification by sequencing a larger region of the tuf
gene. We sequenced a previously described 412 base
pair region of the tuf gene that was reported to have
successfully identified 88% of human-derived staphylo-
coccal strains [60]. However, a more recent publication
that sequenced a 660 bp region of the tuf gene, reported
98.9% identification of 186 human and animal-derived
staphylococcal strains.
We did not detect any MR-CoPS isolates. Other studies
of healthy dogs have similarly reported a low prevalence
[15,82,83]. In contrast, 58% of the dogs in our study carried
at least one CoNS isolate with phenotypic meticillin resist-
ance and 42% carried a meticillin resistant mecA positive
isolate. Other studies have also reported high levels of
meticillin resistance among CoNS isolates from humans
[31,35,84], horses [23,64-66] and livestock [72,85]. How-
ever, the prevalence of MR-CoNS carriage in our study is
markedly higher than the levels reported in other commu-
nity canine studies [15,23,50,74,83]. High community
carriage rates of MR-CoNS are of concern for animals and
humans, as these organisms may not only be reservoirs
of resistance genes for CoPS [39,40,86], but also act as
pathogens [31,36-38,87-89]. Cross-transmission is re-
ported to be an important mechanism for dissemination
of MRS [49,90], and transmission between dogs and
in-contact humans may occur in the community and in
veterinary premises [36,83].
Nine different CoNS species carried the mecA gene in
our study with MRSE detected in 25% of our dogs.
MRSE is the predominant MR-CoNS species in humans
both in hospital and community settings [39,48,49], and
has been reported in one study investigating nasal
carriage of MRS in dogs [23]. Other canine studies have
isolated meticillin resistant S. sciuri and meticillin
resistant S. warneri [23,74]. Our research found that the
majority of the S. sciuri and S. fleurettii isolates were
mecA positive, which is consistent with other studies in
humans, livestock and horses [35,64,66,67,72].MDR CoNS (n = 38) were isolated from 34% of dogs
in this study. MDR was generally associated with resist-
ance to β-lactams, FA and additional antimicrobials. In
particular MDR-MRSE were resistant to at least four anti-
microbial classes tested in our study. A similar finding
was reported in a study of hospitalised animals, medical
equipment and veterinary staff [68]. MDR among CoNS
isolates is widely reported [15,49,72,73,91] and may be
associated with the carriage of multiple antimicrobial re-
sistance genes on SCCmec cassettes [40]. In contrast, the
majority of our commensal CoPS isolates were susceptible
to a broad range of antimicrobials (apart from Tet), in line
with previous reports for clinical isolates [92-94] and iso-
lates from healthy vet-visiting dogs [15]. There was good
to very good agreement between disc and MIC antimicro-
bial susceptibility testing apart for FC and CIP. These two
antimicrobials were the only ones where human break-
points were applied and emphasises potential species
differences in pharmacokinetic and pharmacodynamic
data for individual antimicrobials.
The mecA gene was not identified in 40% of the
phenotypic oxacillin resistant isolates in this study and
may include some isolate duplication due to our sam-
pling methods. Other studies have reported phenotypic
meticillin resistance with absence of the mecA gene in
staphylococci [95-98]. Our OX-resistant mecA negative
isolates may be truly negative for the mecA gene as they
were less likely to be resistant to the other antimicrobials
tested in this study, including CVN and CFX, and had sig-
nificantly lower MICs compared to the OX resistant mecA
positive isolates. It is possible that they had low-level
resistance associated with other mechanisms such as
hyperproduction of β-lactamases [99], or production of an
oxacillin-specific β-lactamases [100]. There are bovine
mastitis CoNS isolates with oxacillin MICs of 0.5 – 1 mg/l
that lack the mecA gene [97], and the CLSI guidelines
state that ‘oxacillin interpretive criteria may overcall resist-
ance for these CoNS strains’ [57]. In addition, many of the
published PCR assays to identify and characterise the
mecA gene have been developed for MRSA [101-104] and
may therefore lack sensitivity for some CoNS isolates.
However, other authors have successfully employed the
same methods for mecA detection among CoNS isolates
as used in our study [68,98,105]. Nevertheless it is possible
that additional PCR assay [106], or latex agglutination for
PBP2a [107] may have improved the sensitivity of mecA
detection or detected phenotypic mecA-associated resist-
ance in our oxacillin resistant mecA negative isolates.
Our study had some limitations, including the small
sample size. Still, these dogs yielded 436 staphylococcal
isolates and a high prevalence of resistance was identi-
fied among the CoNS isolates even in the absence of
antimicrobial exposure. Another weakness was that the
study population was limited to one breed (Labrador
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Kennelled dogs have been shown to have higher levels of
antimicrobial resistance in faecal E. coli than individually
owned and non-kennelled dogs [108]. Kennelling was
transient in our dogs, but this may have affected the
results. Many of the dogs came from multi-dog house-
holds but only one dog from each household was sam-
pled to avoid cluster effects.Conclusions
This is the first comprehensive study of commensal
staphylococcal populations in a group of healthy dogs.
Staphylococci, particularly CoNS, form a normal part of
the canine commensal population and were detected from
almost all the dogs. The most commonly isolated staphylo-
coccal species in this group of dogs was S. epidermidis,
although a wide variety of other human- and animal-
associated CoNS were found. CoPS were less common,
and the major species was S. pseudintermedius. Antimicro-
bial resistance among the CoPS was uncommon, and no
MRSP or MRSA were isolated, however the sample size
was small. Antimicrobial resistance (including MDR and
meticillin resistance) was common among the CoNS
isolates, even though this was a community population of
healthy dogs in the absence of direct-antimicrobial pres-
sure or veterinary contact. The clinical significance of com-
mensal CoNS and MR-CoNS is unclear, but S. epidermidis
carries a number of virulence factors and is an increasing
cause of nosocomial and community-acquired infections in
humans. The possibility of similar infections escalating in
companion animals cannot be excluded. In addition, there
is potential for cross-species transmission of antimicrobial
resistant bacteria and exchange of resistance determinants
between bacterial species. In particular, MR- and MDR-
CoNS may provide a reservoir of antimicrobial resistance
genes that could rapidly spread within bacterial popula-
tions under the selection pressure exerted by antimicrobial
therapy. Further longitudinal studies in healthy dogs and in
dogs receiving antimicrobials are required to assess the
population diversity, antimicrobial resistance profiles and
persistence of antimicrobial resistant staphylococci in dogs.
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